Do high levels of IgA rheumatoid factor indicate a poor response to treatment with TNF inhibitors in patients with RA?

被引：3
作者：
van Laar, Jacob M. [1 ]
机构：
[1] Univ Newcastle Upon Tyne, Sch Clin Med Sci, Inst Cellular Med, Musculoskeletal Res Grp,Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
来源：
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2007年 / 3卷 / 10期
关键词：
predictor; rheumatoid arthritis; rheumatoid factor; response; TNF;
D O I：
10.1038/ncprheum0596
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：544 / 545
页数：2
相关论文
共 50 条
  • [31] Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?' by Nocturne et al
    Mercer, Louise K.
    Galloway, James B.
    Lunt, Mark
    Davies, Rebecca
    Low, Audrey A. L.
    Dixon, Will G.
    Watson, Kath D.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (02)
  • [32] Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-α inhibitors
    Aeberli, D
    Seitz, M
    Jüni, P
    Villiger, PM
    RHEUMATOLOGY, 2005, 44 (02) : 172 - 175
  • [33] Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach
    Hye-Lin Kim
    Min-Young Lee
    Sun-Young Park
    Sun-Kyeong Park
    Ji-Hye Byun
    Sunhong Kwon
    Eui-Kyung Lee
    Archives of Pharmacal Research, 2014, 37 : 662 - 670
  • [34] Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach
    Kim, Hye-Lin
    Lee, Min-Young
    Park, Sun-Young
    Park, Sun-Kyeong
    Byun, Ji-Hye
    Kwon, Sunhong
    Lee, Eui-Kyung
    ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (05) : 662 - 670
  • [35] Increased healthcare resource utilization in higher disease activity levels in initiators of TNF inhibitors among US rheumatoid arthritis patients
    Boytsov, Natalie
    Harrold, Leslie R.
    Mason, Marc A.
    Gaich, Carol L.
    Zhang, Xiang
    Larmore, Cynthia J.
    Rebello, Sabrina
    Araujo, Andre B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (12) : 1959 - 1967
  • [36] Presence of anti-cyclic citrullinated peptide antibodies is associated with better treatment response to abatacept but not to TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis
    Alemao, E.
    Postema, R.
    Elbez, Y.
    Mamane, C.
    Finckh, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (03) : 455 - 466
  • [37] Vitamin B-6 Status Correlates with Disease Activity in Rheumatoid Arthritis Patients During Treatment with TNFα Inhibitors
    Sande, Jon Sigurd
    Ulvik, Arve
    Midttun, Oivind
    Ueland, Per M.
    Hammer, Hilde B.
    Valen, Merete
    Apalset, Ellen M.
    Gjesdal, Clara G.
    JOURNAL OF NUTRITION, 2019, 149 (05) : 770 - 775
  • [38] Clonal expansions in selected TCR BV families of rheumatoid arthritis patients are reduced by treatment with the TNFα inhibitors etanercept and infliximab
    Pierer, Matthias
    Rossol, Manuela
    Kaltenhaeuser, Sylke
    Arnold, Sybille
    Haentzschel, Holm
    Baerwald, Christoph
    Wagner, Ulf
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (08) : 1023 - 1029
  • [39] Clonal expansions in selected TCR BV families of rheumatoid arthritis patients are reduced by treatment with the TNFα inhibitors etanercept and infliximab
    Matthias Pierer
    Manuela Rossol
    Sylke Kaltenhäuser
    Sybille Arnold
    Holm Häntzschel
    Christoph Baerwald
    Ulf Wagner
    Rheumatology International, 2011, 31 : 1023 - 1029
  • [40] Serum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis
    Kasama, Tsuyoshi
    Isojima, Sakiko
    Umemura, Masayu
    Tsukamoto, Hiroyuki
    Tokunaga, Takehiro
    Furuya, Hidekazu
    Yanai, Ryo
    Takahashi, Ryo
    Nakamura, Masanori
    Inagaki, Katsunori
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (03) : 429 - 433
12345